Article
Current and Emerging Biomarkers in Metastatic Colorectal Cancer
1 Nov 2019
Abstract excerpt
Background: The incorporation of novel biomarkers into therapy selection for patients with metastatic colorectal cancer (mcrc) has significantly improved outcomes. Optimal treatment planning now takes into account diverse characteristics of patients and their tumours to create personalized therapeutic plans. Discussion: This review is split into two sections. In the first section, we review the prognostic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
